Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Dose Escalation for Non-small Cell Lung Cancer (NSCLC) Using Volumetric Modulated Arc Therapy (VMAT)

NCT01577212 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT01577212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01577212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Dose Escalation for Non-small Cell Lung Cancer (NSCLC) Using Volumetric Modulated Arc Therapy (VMAT)
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2012
Completion date
September 30, 2014
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

individualized radiation dose escalation, stage iii non-small cell lung cancer